1. Home
  2. EDSA vs VRME Comparison

EDSA vs VRME Comparison

Compare EDSA & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • VRME
  • Stock Information
  • Founded
  • EDSA 2015
  • VRME 1999
  • Country
  • EDSA Canada
  • VRME United States
  • Employees
  • EDSA N/A
  • VRME N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • VRME EDP Services
  • Sector
  • EDSA Health Care
  • VRME Technology
  • Exchange
  • EDSA Nasdaq
  • VRME Nasdaq
  • Market Cap
  • EDSA 6.1M
  • VRME 6.4M
  • IPO Year
  • EDSA N/A
  • VRME N/A
  • Fundamental
  • Price
  • EDSA $1.73
  • VRME $0.63
  • Analyst Decision
  • EDSA Strong Buy
  • VRME Buy
  • Analyst Count
  • EDSA 1
  • VRME 1
  • Target Price
  • EDSA $21.00
  • VRME $1.50
  • AVG Volume (30 Days)
  • EDSA 30.6K
  • VRME 240.7K
  • Earning Date
  • EDSA 02-07-2025
  • VRME 11-12-2024
  • Dividend Yield
  • EDSA N/A
  • VRME N/A
  • EPS Growth
  • EDSA N/A
  • VRME N/A
  • EPS
  • EDSA N/A
  • VRME N/A
  • Revenue
  • EDSA N/A
  • VRME $25,259,000.00
  • Revenue This Year
  • EDSA N/A
  • VRME N/A
  • Revenue Next Year
  • EDSA N/A
  • VRME $5.00
  • P/E Ratio
  • EDSA N/A
  • VRME N/A
  • Revenue Growth
  • EDSA N/A
  • VRME N/A
  • 52 Week Low
  • EDSA $1.55
  • VRME $0.58
  • 52 Week High
  • EDSA $5.99
  • VRME $2.45
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 31.51
  • VRME 36.27
  • Support Level
  • EDSA $1.73
  • VRME $0.59
  • Resistance Level
  • EDSA $1.99
  • VRME $0.68
  • Average True Range (ATR)
  • EDSA 0.19
  • VRME 0.07
  • MACD
  • EDSA 0.02
  • VRME 0.02
  • Stochastic Oscillator
  • EDSA 18.00
  • VRME 29.00

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

Share on Social Networks: